The company saw a 60 percent increase in revenue during the fourth quarter of 2021 compared to the fourth quarter of 2020.
Implanet saw growth in its spine business, although it noted that activity in the U.S. was heavily affected by COVID-19. U.S. revenue declined 20 percent.
The company said it plans to finalize the globalization of its spine surgery products in 2022 while strengthening its presence in the U.S. and seeking more partnerships.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
